CoChat

Diabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

The pathogenesis of diabetes-associated motility disorders are multifactorial and attributed to abnormalities in extrinsic and intrinsic innervation, and a decrease in the number of interstitial cells of Cajal, and nNOS expression and activity. Here we studied the effect of hyperglycemia on smooth muscle function. Using smooth muscles from the fundus of ob/ob mice and of wild type (WT) mice treated with 30 mM glucose (HG), we identified the molecular mechanism by which hyperglycemia upregulates RhoA/Rho kinase pathway and muscle contraction. RhoA expression, Rho kinase activity and muscle contraction were increased, while miR-133a expression was decreased in smooth muscle of ob/ob mice and in smooth muscle treated with HG. Intraperitoneal injections of pre-miR-133a decreased RhoA expression in WT mice and reversed the increase in RhoA expression in ob/ob mice. Intraperitoneal injections of antagomiR-133a increased RhoA expression in WT mice and augmented the increase in RhoA expression in ob/ob mice. The effect of pre-miR-133a or antagomiR-133a in vitro in smooth muscle treated with HG was similar to that obtained in vivo, suggesting that the expression of RhoA is negatively regulated by miR-133a and a decrease in miR-133a expression in diabetes causes an increase in RhoA expression. Oxidative stress (levels of reactive oxygen species and hydrogen peroxide, and expression of superoxide dismutase 1 and NADPH oxidase 4) was increased in smooth muscle of ob/ob mice and in HG-treated smooth muscle. Treatment of ob/ob mice with N-acetylcysteine (NAC) in vivo or addition of NAC in vitro to HG-treated smooth muscle reversed the effect of glucose on the expression of miR-133a and RhoA, Rho kinase activity and muscle contraction. NAC treatment also reversed the decrease in gastric emptying in ob/ob mice. We conclude that oxidative stress in diabetes causes a decrease in miR-133a expression leading to an increase in RhoA/Rho kinase pathway and muscle contraction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0178574

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Expression of RhoA, Rho kinase activity and muscle contraction in diabetes and hyperglycemia. Smooth muscle of the fundus of wild type (WT) and ob/ob mice and smooth muscle from WT mice treated with 5.5 mM (NG) or 30 mM glucose (HG) for 48 h were used to measure the expression of RhoA, Rho kinase activity, MYPT1 phosphorylation and muscle contraction. (A, B, F, G) Expression of RhoA was measured by qRT-PCR and western blot and results with mRNA was expressed as fold change. The molecular weight of RhoA is 24 kDa. Values are means±SE of 4–6 experiments. (C and H) Rho kinase activity was measured in response to acetylcholine (ACh, 1μM) by immunokinase assay and the results are expressed as cpm/mg protein. Values are means±SE of 4–6 experiments. (D and I) MYPT1 phosphorylation was measured by western blot using phospho-specific antibody. The molecular weight of MYPT1 is 140 kDa. (E and J) Muscle contraction was measured as an increase in sustained contraction in response to acetylcholine (10 μM) in organ bath experiments and the results are expressed as mN/100 mg of tissue. Values are means±SE of 4–6 experiments.
Fig 1 Expression of RhoA, Rho kinase activity and muscle contraction in diabetes and hyperglycemia. Smooth muscle of the fundus of wild type (WT) and ob/ob mice and smooth muscle from WT mice treated with 5.5 mM (NG) or 30 mM glucose (HG) for 48 h were used to measure the expression of RhoA, Rho kinase activity, MYPT1 phosphorylation and muscle contraction. (A, B, F, G) Expression of RhoA was measured by qRT-PCR and western blot and results with mRNA was expressed as fold change. The molecular weight of RhoA is 24 kDa. Values are means±SE of 4–6 experiments. (C and H) Rho kinase activity was measured in response to acetylcholine (ACh, 1μM) by immunokinase assay and the results are expressed as cpm/mg protein. Values are means±SE of 4–6 experiments. (D and I) MYPT1 phosphorylation was measured by western blot using phospho-specific antibody. The molecular weight of MYPT1 is 140 kDa. (E and J) Muscle contraction was measured as an increase in sustained contraction in response to acetylcholine (10 μM) in organ bath experiments and the results are expressed as mN/100 mg of tissue. Values are means±SE of 4–6 experiments.CC BY · PubMed Central
Fig 2 Expression of microRNA-133a in diabetes and hyperglycemia. (A) Expression of microRNA-133a (miR-133a) was measured by qRT-PCR in RNA isolated from the smooth muscle of WT or ob/ob mice with or without intraperitoneal injections of pre- miR-133a (5 mg/kg of body weight over 3 days). (B) Expression of miR-133a was measured by qRT-PCR in RNA isolated from the smooth muscle cells treated with NG or HG for 48 h in the presence or absence of transfection with pre-miR-133a. Values are means±SE of 3–5 experiments.
Fig 2 Expression of microRNA-133a in diabetes and hyperglycemia. (A) Expression of microRNA-133a (miR-133a) was measured by qRT-PCR in RNA isolated from the smooth muscle of WT or ob/ob mice with or without intraperitoneal injections of pre- miR-133a (5 mg/kg of body weight over 3 days). (B) Expression of miR-133a was measured by qRT-PCR in RNA isolated from the smooth muscle cells treated with NG or HG for 48 h in the presence or absence of transfection with pre-miR-133a. Values are means±SE of 3–5 experiments.CC BY · PubMed Central
Fig 3 Regulation of RhoA expression and Rho kinase activity by miR-133a in diabetes and hyperglycemia. Expression of RhoA and Rho kinase activity was measured in the smooth muscle of WT or ob/ob mice with or without intraperitoneal injections pre-miR-133a or antagomiR-miR133a (5 mg/kg of body weight over 3 days) (A, B, E and F) and in smooth muscle cells treated with NG or HG for 48 h in the presence or absence of transfection with pre-miR-133a or antagomiR-133a (C and G). RhoA mRNA expression was measured by qRT-PCR and the results are expressed as fold increase from control. RhoA protein expression was measured by western blot and the results are expressed as densitometric values. The molecular weights of RhoA and β-Actin are 24 and 42 kDa, respectively. (D) Rho kinase activity was measured by immunokinase assay and the results are expressed as cpm/mg protein. Values are means±SE of 3–5 experiments.
Fig 3 Regulation of RhoA expression and Rho kinase activity by miR-133a in diabetes and hyperglycemia. Expression of RhoA and Rho kinase activity was measured in the smooth muscle of WT or ob/ob mice with or without intraperitoneal injections pre-miR-133a or antagomiR-miR133a (5 mg/kg of body weight over 3 days) (A, B, E and F) and in smooth muscle cells treated with NG or HG for 48 h in the presence or absence of transfection with pre-miR-133a or antagomiR-133a (C and G). RhoA mRNA expression was measured by qRT-PCR and the results are expressed as fold increase from control. RhoA protein expression was measured by western blot and the results are expressed as densitometric values. The molecular weights of RhoA and β-Actin are 24 and 42 kDa, respectively. (D) Rho kinase activity was measured by immunokinase assay and the results are expressed as cpm/mg protein. Values are means±SE of 3–5 experiments.CC BY · PubMed Central
Fig 4 Oxidative stress in diabetes and hyperglycemia. Smooth muscle of the fundus of WT and ob/ob mice and smooth muscle from WT mice treated with NG or HG for 48 h were used to measure expression of the RAGE, SOD-1 and level of H2O2 and ROS. (A, B, G and H) Expression of RAGE was measured by qRT-PCR and western blot and results with mRNA was expressed as fold change. Values are means±SE of 4–6 experiments. (C and I) Expression of SOD-1 was measured by qRT-PCR and the results are expressed as fold increase from control. Values are means±SE of 4–6 experiments. (D and J) H2O2 levels were measured by calorimetry and the results are expressed as μM/100 mg. Values are means±SE of 4–6 experiments. (E and K) ROS levels were measured by fluorometry and the results are expressed as percent increase from control. Values are means±SE of 4–6 experiments. (F) MPO levels were measured by fluorometry and the results are expressed as percent increase from control. Values are means±SE of 4–5 experiments.
Fig 4 Oxidative stress in diabetes and hyperglycemia. Smooth muscle of the fundus of WT and ob/ob mice and smooth muscle from WT mice treated with NG or HG for 48 h were used to measure expression of the RAGE, SOD-1 and level of H2O2 and ROS. (A, B, G and H) Expression of RAGE was measured by qRT-PCR and western blot and results with mRNA was expressed as fold change. Values are means±SE of 4–6 experiments. (C and I) Expression of SOD-1 was measured by qRT-PCR and the results are expressed as fold increase from control. Values are means±SE of 4–6 experiments. (D and J) H2O2 levels were measured by calorimetry and the results are expressed as μM/100 mg. Values are means±SE of 4–6 experiments. (E and K) ROS levels were measured by fluorometry and the results are expressed as percent increase from control. Values are means±SE of 4–6 experiments. (F) MPO levels were measured by fluorometry and the results are expressed as percent increase from control. Values are means±SE of 4–5 experiments.CC BY · PubMed Central
Fig 5 Expression of NOX-4 and microRNA-25 in diabetes and hyperglycemia. Smooth muscle of the fundus from WT and ob/ob mice, and smooth muscle of the fundus from WT mice treated with NG or HG for 48 h were used to measure the expression of NOX-4 and microRNA-25 (miR-25). (A and C) Analysis of NOX-4 expression by western blot. The molecular weights of NOX4 and β-actin are 67 and 42 kDa, respectively. (B and D) mRNA expression of NOX-4 was measured by qRT-PCR and the results are expressed as fold change. Values are means±SE of 4–6 experiments. (E and F) Expression of miR-25 was measured by qRT-PCR and results are expressed as fold change. Values are means±SE of 4–6 experiments.
Fig 5 Expression of NOX-4 and microRNA-25 in diabetes and hyperglycemia. Smooth muscle of the fundus from WT and ob/ob mice, and smooth muscle of the fundus from WT mice treated with NG or HG for 48 h were used to measure the expression of NOX-4 and microRNA-25 (miR-25). (A and C) Analysis of NOX-4 expression by western blot. The molecular weights of NOX4 and β-actin are 67 and 42 kDa, respectively. (B and D) mRNA expression of NOX-4 was measured by qRT-PCR and the results are expressed as fold change. Values are means±SE of 4–6 experiments. (E and F) Expression of miR-25 was measured by qRT-PCR and results are expressed as fold change. Values are means±SE of 4–6 experiments.CC BY · PubMed Central
Fig 6 Effect of N-acetylcysteine (NAC) on the expression of miR-133 and RhoA, and muscle contraction in diabetes and hyperglycemia. (A and E) Expression of miR-133a was measured by qRT-PCR in RNA isolated from the smooth muscle of WT or ob/ob mice with or without intraperitoneal (IP) injections of NAC (300 mg/kg) and in RNA isolated from smooth muscle cells treated with NG or HG for 48 h in the presence or absence of NAC (1 mM). Results are expressed as fold change from control. Values are means±SE of 4–6 experiments. (B, C, F and G) Expression of RhoA was measured by qRT-PCR and western blot in smooth muscle of WT or ob/ob mice with or without IP injections of NAC (300 mg/kg) and in smooth muscle cells treated with NG or HG for 48 h in the presence or absence of NAC. Results are expressed as fold change from control for mRNA levels. The molecular weights of RhoA and β-actin are 24 and 42 kDa, respectively. Values are means±SE of 4–6 experiments. (H) Rho kinase activity was measured in response to acetylcholine (ACh, 1μM) by immunokinase assay and the results are expressed as cpm/mg protein. Values are means±SE of 4–5 experiments. (D and I) Muscle contraction was measured as increase in sustained contraction in response to acetylcholine (10 μM) in organ bath experiments in smooth muscle of WT or ob/ob mice with or without IP injections NAC (300 mg/kg) and in smooth muscle treated with NG or HG for 48 h in the presence or absence of NAC (1mM). Results are expressed as mN/100 mg of tissue. Values are means±SE of 4–6 experiments.
Fig 6 Effect of N-acetylcysteine (NAC) on the expression of miR-133 and RhoA, and muscle contraction in diabetes and hyperglycemia. (A and E) Expression of miR-133a was measured by qRT-PCR in RNA isolated from the smooth muscle of WT or ob/ob mice with or without intraperitoneal (IP) injections of NAC (300 mg/kg) and in RNA isolated from smooth muscle cells treated with NG or HG for 48 h in the presence or absence of NAC (1 mM). Results are expressed as fold change from control. Values are means±SE of 4–6 experiments. (B, C, F and G) Expression of RhoA was measured by qRT-PCR and western blot in smooth muscle of WT or ob/ob mice with or without IP injections of NAC (300 mg/kg) and in smooth muscle cells treated with NG or HG for 48 h in the presence or absence of NAC. Results are expressed as fold change from control for mRNA levels. The molecular weights of RhoA and β-actin are 24 and 42 kDa, respectively. Values are means±SE of 4–6 experiments. (H) Rho kinase activity was measured in response to acetylcholine (ACh, 1μM) by immunokinase assay and the results are expressed as cpm/mg protein. Values are means±SE of 4–5 experiments. (D and I) Muscle contraction was measured as increase in sustained contraction in response to acetylcholine (10 μM) in organ bath experiments in smooth muscle of WT or ob/ob mice with or without IP injections NAC (300 mg/kg) and in smooth muscle treated with NG or HG for 48 h in the presence or absence of NAC (1mM). Results are expressed as mN/100 mg of tissue. Values are means±SE of 4–6 experiments.CC BY · PubMed Central
Fig 7 Delayed gastric emptying in diabetes. WT and ob/ob mice were treated with IP injections of NAC (300 mg/kg) and fasted for 24 h and then fed normal chow ad libitum for 4 h. Gastric emptying was monitored immediately after 3 h of feeding. Results are expressed as the amount of leftover food in the stomach as milligrams per gram of body weight. Values are means±SE of 4 experiments.
Fig 7 Delayed gastric emptying in diabetes. WT and ob/ob mice were treated with IP injections of NAC (300 mg/kg) and fasted for 24 h and then fed normal chow ad libitum for 4 h. Gastric emptying was monitored immediately after 3 h of feeding. Results are expressed as the amount of leftover food in the stomach as milligrams per gram of body weight. Values are means±SE of 4 experiments.CC BY · PubMed Central
Fig 8 Schematic diagram of the mechanism involved in the upregulation of RhoA/Rho kinase pathway and hypercontraction in diabetes. In smooth muscle, activation of RhoA by contractile agonist causes stimulation of Rho kinase activity and Rho kinase-dependent phosphorylation of MYPT1 resulting in inhibition of MLCP activity and increase in MLC20 phosphorylation and muscle contraction. In diabetic smooth muscle, oxidative stress causes upregulation of RhoA/Rho kinase pathway and hypercontraction. The decrease in miR-133a expression in response to oxidative stress leads to an increase in RhoA expression, Rho kinase activity, MYPT1 phosphorylation and muscle contraction.
Fig 8 Schematic diagram of the mechanism involved in the upregulation of RhoA/Rho kinase pathway and hypercontraction in diabetes. In smooth muscle, activation of RhoA by contractile agonist causes stimulation of Rho kinase activity and Rho kinase-dependent phosphorylation of MYPT1 resulting in inhibition of MLCP activity and increase in MLC20 phosphorylation and muscle contraction. In diabetic smooth muscle, oxidative stress causes upregulation of RhoA/Rho kinase pathway and hypercontraction. The decrease in miR-133a expression in response to oxidative stress leads to an increase in RhoA expression, Rho kinase activity, MYPT1 phosphorylation and muscle contraction.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 33

Metadata

Authors
Mahavadi, S., Sriwai, W., Manion, O., Grider, J. R., & Murthy, K. S.
Affiliations
Virginia Commonwealth University (US)
Corresponding author
Mahavadi, Sunila
Venue
PLoS ONE
Published
2017-07-05
Volume
12
Issue
7
Pages
e0178574
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2727744594
Cited by
31
References
73
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 3
FWCI
3.44
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (DK28300)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
diabetes mellitus, hyperglycemia, oxidative stress, RhoA/Rho-kinase pathway, gastric smooth muscle, miR-133a, ob/ob mice, N-acetylcysteine, gastric emptying, reactive oxygen species, NOX4, superoxide dismutase 1
MeSH terms
Acetylcysteine, Animals, Cells, Cultured, Diabetes Mellitus, Gastric Mucosa, Glucose, Hyperglycemia, Mice, Inbred C57BL, Mice, Obese, Muscle Contraction, Muscle, Smooth, Stomach, Blotting, Western, Signal Transduction, Up-Regulation, Gene Expression, Free Radical Scavengers, Oxidative Stress, Reverse Transcriptase Polymerase Chain Reaction, rhoA GTP-Binding Protein, MicroRNAs, rho-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.